These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36948767)

  • 1. Solving the insoluble: calciprotein particles mediate bulk mineral transport.
    Jahnen-Dechent W; Pasch A
    Kidney Int; 2023 Apr; 103(4):663-665. PubMed ID: 36948767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calciprotein particles: mineral behaving badly?
    Smith ER; Hewitson TD; Jahnen-Dechent W
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):378-386. PubMed ID: 32404635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.
    Miura Y; Iwazu Y; Shiizaki K; Akimoto T; Kotani K; Kurabayashi M; Kurosu H; Kuro-O M
    Sci Rep; 2018 Jan; 8(1):1256. PubMed ID: 29352150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fetuin-A in physiological and pathological mineralization.
    Brylka L; Jahnen-Dechent W
    Calcif Tissue Int; 2013 Oct; 93(4):355-64. PubMed ID: 23277412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate.
    Babler A; Schmitz C; Buescher A; Herrmann M; Gremse F; Gorgels T; Floege J; Jahnen-Dechent W
    PLoS One; 2020; 15(2):e0228938. PubMed ID: 32074140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease.
    Holt SG; Smith ER
    Nephrol Dial Transplant; 2016 Oct; 31(10):1583-7. PubMed ID: 27190332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity.
    Herrmann M; Babler A; Moshkova I; Gremse F; Kiessling F; Kusebauch U; Nelea V; Kramann R; Moritz RL; McKee MD; Jahnen-Dechent W
    PLoS One; 2020; 15(2):e0228503. PubMed ID: 32074120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical transformation of calciprotein particles in uraemia.
    Smith ER; Hewitson TD; Hanssen E; Holt SG
    Bone; 2018 May; 110():355-367. PubMed ID: 29499417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.
    Heiss A; DuChesne A; Denecke B; Grötzinger J; Yamamoto K; Renné T; Jahnen-Dechent W
    J Biol Chem; 2003 Apr; 278(15):13333-41. PubMed ID: 12556469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineral metabolism and aging.].
    Kuro-O M
    Clin Calcium; 2019; 29(2):165-170. PubMed ID: 30679396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcification propensity predicts all-cause mortality in predialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Bodenham E; McMahon LP; Farese S; Rajkumar C; Holt SG; Pasch A
    J Am Soc Nephrol; 2014 Feb; 25(2):339-48. PubMed ID: 24179171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.
    Smith ER; Hanssen E; McMahon LP; Holt SG
    PLoS One; 2013; 8(4):e60904. PubMed ID: 23577176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure.
    Smith ER; Cai MM; McMahon LP; Pedagogos E; Toussaint ND; Brumby C; Holt SG
    Nephrology (Carlton); 2013 Mar; 18(3):215-21. PubMed ID: 23231493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.